Christophe Hermelin

Christophe Hermelin, an accomplished inventor based in Chaingy, France, has made a significant impact in the pharmaceutical industry with his innovative contributions. With a focus on improving drug delivery systems, Hermelin holds a patent that showcases his expertise and dedication to enhancing patient care.

Latest Patents

Hermelin's notable patent is titled "Pharmaceutical composition for the prolonged release of trimetazidine." This innovative composition is designed for the prolonged release of trimetazidine, featuring an inner phase that comprises the active ingredient trimetazidine and an outer layer containing a retardant and an anti-agglomerant. This formulation aims to enhance the effectiveness and compliance of treatment for patients requiring this medication.

Career Highlights

Hermelin is currently employed at Les Laboratoires Servier, a reputable pharmaceutical company known for its commitment to research and development in various therapeutic areas. His role within the organization allows him to contribute his knowledge and skills towards creating advanced pharmaceutical solutions.

Collaborations

Throughout his career, Hermelin has had the privilege of collaborating with esteemed colleagues such as Patrick Genty and Jean-Manuel Pean. These professional relationships have fostered a collaborative environment that promotes innovation and the sharing of ideas, ultimately leading to the successful development of noteworthy pharmaceutical compositions.

Conclusion

Christophe Hermelin exemplifies the spirit of innovation and dedication in the field of pharmaceuticals. His patent reflects not only his technical prowess but also his commitment to improving healthcare outcomes. As a key player at Les Laboratoires Servier, Hermelin continues to pave the way for future advancements in drug delivery systems.

Profile summary based on public USPTO records.